Commonwealth Equity Services
AMED

Commonwealth Equity Services’s Amedisys AMED Stock Holding History

Commonwealth Equity Services’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,591
Closed -$452K – 4236
2025
Q2 		$452K Buy
4,591
+1,009
+28% +$95.5K ﹤0.01% 3228
2025
Q1 		$332K Sell
3,582
-259
-7% -$23.9K ﹤0.01% 3410
2024
Q4 		$349K Sell
3,841
-332
-8% -$30.5K ﹤0.01% 3281
2024
Q3 		$403K Buy
4,173
+22
+0.5% +$2.15K ﹤0.01% 3087
2024
Q2 		$381K Buy
4,151
+409
+11% +$38K ﹤0.01% 3078
2024
Q1 		$345K Buy
3,742
+6
+0.2% +$562 ﹤0.01% 3144
2023
Q4 		$355K Sell
3,736
-160
-4% -$14.9K ﹤0.01% 3012
2023
Q3 		$364K Buy
3,896
+110
+3% +$10.2K ﹤0.01% 2860
2023
Q2 		$346K Sell
3,786
-3
-0.1% -$246 ﹤0.01% 2926
2023
Q1 		$278 Sell
3,789
-4
-0.1% -$346 ﹤0.01% 3025
2022
Q4 		$316K Sell
3,793
-46
-1% -$4.15K ﹤0.01% 2823
2022
Q3 		$371K Sell
3,839
-39
-1% -$4.65K ﹤0.01% 2646
2022
Q2 		$407K Sell
3,878
-822
-17% -$105K ﹤0.01% 2569
2022
Q1 		$809K Buy
4,700
+62
+1% +$9.26K ﹤0.01% 2151
2021
Q4 		$750K Sell
4,638
-116
-2% -$18.6K ﹤0.01% 2203
2021
Q3 		$708K Buy
4,754
+137
+3% +$28.5K ﹤0.01% 2204
2021
Q2 		$1.13M Buy
4,617
+153
+3% +$40.1K ﹤0.01% 1825
2021
Q1 		$1.18M Sell
4,464
-622
-12% -$175K ﹤0.01% 1678
2020
Q4 		$1.49M Sell
5,086
-1,786
-26% -$458K ﹤0.01% 1401
2020
Q3 		$1.62M Buy
6,872
+2,795
+69% +$635K 0.01% 1208
2020
Q2 		$809K Buy
4,077
+56
+1% +$10.4K ﹤0.01% 1554
2020
Q1 		$738K Sell
4,021
-135
-3% -$24K ﹤0.01% 1439
2019
Q4 		$693K Buy
4,156
+20
+0.5% +$2.98K ﹤0.01% 1666
2019
Q3 		$541K Buy
4,136
+215
+5% +$28K ﹤0.01% 1769
2019
Q2 		$476K Buy
3,921
+7
+0.2% +$831 ﹤0.01% 1836
2019
Q1 		$482K Buy
3,914
+210
+6% +$26.4K ﹤0.01% 1784
2018
Q4 		$433K Buy
3,704
+95
+3% +$11.2K ﹤0.01% 1741
2018
Q3 		$450K Buy
3,609
+36
+1% +$3.98K ﹤0.01% 1852
2018
Q2 		$305K Buy
3,573
+49
+1% +$3.6K ﹤0.01% 2100
2018
Q1 		$212K Buy
+3,524
New +$201K ﹤0.01% 2352
2017
Q3 		– Sell
-4,139
Closed -$260K – 2567
2017
Q2 		$260K Buy
4,139
+111
+3% +$6.46K ﹤0.01% 2023
2017
Q1 		$206K Buy
+4,028
New +$192K ﹤0.01% 2126
2016
Q4 		– Sell
-8,628
Closed -$409K – 2319
2016
Q3 		$409K Sell
8,628
-602
-7% -$30K ﹤0.01% 1499
2016
Q2 		$466K Sell
9,230
-249
-3% -$12.6K ﹤0.01% 1401
2016
Q1 		$458K Sell
9,479
-200
-2% -$7.72K ﹤0.01% 1369
2015
Q4 		$381K Buy
9,679
+1,242
+15% +$49.7K ﹤0.01% 1443
2015
Q3 		$320K Buy
8,437
+600
+8% +$25.3K ﹤0.01% 1510
2015
Q2 		$311K Sell
7,837
-1,040
-12% -$32.4K ﹤0.01% 1612
2015
Q1 		$238K Buy
8,877
+1,757
+25% +$49.6K ﹤0.01% 1783
2014
Q4 		$209K Buy
+7,120
New +$176K ﹤0.01% 1819
2013
Q4 		– Sell
-13,121
Closed -$226K – 1927
2013
Q3 		$226K Sell
13,121
-699
-5% -$10.4K ﹤0.01% 1562
2013
Q2 		$160K Buy
+13,820
New +$158K ﹤0.01% 1621

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Commonwealth Equity Services's AMED Position: Q3 2025 in Review

Commonwealth Equity Services sold out of Amedisys (AMED) in Q3 2025, closing a stake of 4,591 shares — an estimated $452K sold.

Commonwealth Equity Services first reported a position in AMED in Q2 2013 and held it in 42 quarters. The position peaked at $1.62M in Q3 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Commonwealth Equity Services reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 4,591 Amedisys shares in Q3 2025, an estimated $452K.
  • Commonwealth Equity Services first reported a position in Amedisys in Q2 2013 and held it in 42 quarters.
  • Commonwealth Equity Services's Amedisys position peaked at $1.62M in Q3 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Commonwealth Equity Services's 13F filing for Q3 2025, filed 22 Oct 2025.